Clinical Trials Browser

Phase 4 × trastuzumab deruxtecan × 1 year × Clear all

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Phase 4 Recruiting

Brain Neoplasms, Breast Neoplasms

NCT06429761 2025-11-24

STRIDE

Phase 4 Recruiting

Breast Neoplasms